United States· US:73473-903_45ce210f-125d-12f6-e063-6394a90a9f9b

Moxifloxacin

A moxifloxacin product containing moxifloxacin hydrochloride, registered in United States by Solaris Pharma Corporation. The same ATC class is registered in 16 of our 19 countries.

ATC J01MA14US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about moxifloxacin hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Moxifloxacin is registered in 16 of 19 countries.

Countries holding a registration under ATC J01MA14 (moxifloxacin), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search moxifloxacin products by name

Moxifloxacin · ATC J01MA14

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of moxifloxacin costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $1.34 in United States to $6.89 in Switzerland — a ×5.2 gap.

United States: $1.34 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Moxifloxacin · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$6.89
IT Italy$1.99
US United States$1.34 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: MOXIFLOXACIN HYDROCHLORIDE
Manufacturer: Solaris Pharma Corporation
Country: United States (US)
ATC code: J01MA14
ATC class: Moxifloxacin
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
7347390330
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (73473-903-30)
ndc11
73473-903-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

531 interactions on record for moxifloxacin.

Graded by severity as the source publishes them — 175 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check moxifloxacin against other medicines How interaction checks work

Moxifloxacin · interactions on record

531 records

175 severe
140 moderate
49 minor
92 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe

75 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Moxifloxacin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All moxifloxacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Avelox, Moxifloxacin 1a Pharma
Belgium · Avelox, Kanavig
Bulgaria · Cimocinox, Moxifloxacin Kabi
Cyprus · Avelox, Erelan
Czechia · Avelox, Moxifloxacin Brown & Burk
Germany · Avalox, Moxifloxacin 1 A Pharma
Denmark · Moxifloxacin Accord, Moxifloxacin Fresenius Kabi
Estonia · Avelox, Floxelan
Spain · Abimox, Actira
Finland · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
France · Izilox, Moxifloxacine Arrow
United Kingdom (Northern Ireland) · Avelox, Moxidox
Greece · Avelox, Mikrobiel
Croatia · Melvedok, Moksacin 5 Mg/Ml Kapi
Hungary · Moxibiot, Moxifloxacin Anfarm
Ireland · Moxifloxacin
Iceland · Vigamox
Italy · Avalox, Moxidrop
Lithuania · Avelox, Ekara
Luxembourg · Avelox, Kanavig
Latvia · Avelox, Ekara
Malta · Erelan, Moxifloxacin Anfarm
Netherlands · Erelan, Moxifloxacin Hydrochloride Aurobindo
Norway · Xinaflox
Poland · Flomixa, Floxamic Neo
Portugal · Avelox, Bluesar
Romania · Avelox, Kimoks
Sweden · Moxifloxacin Fresenius Kabi, Moxifloxacin Krka
Slovenia · Kimoks, Moksifloksacin Kabi
Slovakia · Avelox, Moloxin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7e83bd91-69b0-4e06-808d-7d8e1b9f2079
GET /v1/drugs/7e83bd91-69b0-4e06-808d-7d8e1b9f2079?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "400",
  "substance": "MOXIFLOXACIN HYDROCHLORIDE",
  "productndc": "73473-903",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA206295",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about moxifloxacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console